We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Advanced Cell Diagnostics and Definiens Develop Quantitative Biomarker Tools

By LabMedica International staff writers
Posted on 25 Apr 2011
A technological leader in molecular pathology, Advanced Cell Diagnostics (ACD; Hayward, CA, USA), has partnered with a provider for biomedical imaging and data analyses.

The biomedical image company Definiens (Munich, Germany) will develop a unique and proprietary image analysis application for ACD that provides users with powerful analysis capabilities.

Under the agreement, Definiens will develop a unique and proprietary image analysis application for ACD that provides users with powerful analysis capabilities. Definiens software, based on its Definiens XD framework, offers users with accurate, robust, and scalable image analysis solutions for a wide range of histology analysis. The strategic partnership will develop image analysis applications that will enable scientists to quantify specific ribonucleic acid (RNA) molecules accurately within individual cells in routine clinical specimen. The joint venture will build on ACD's RNAscope platform and add new specialized image analysis solutions that will automatically process and analyze images from RNAscope assays.

ACD's RNAscope is a novel and proprietary RNA in situ hybridization (ISH) method that can detect and quantify virtually any expressed gene at single molecule sensitivity in individual cells in all major biological specimen types, including cell lines, peripheral blood mononuclear cells and formalin-fixed paraffin embedded tissue sections. As the most clinically robust RNA ISH assay available, RNAscope enables the fastest path from genomic discovery to validated biomarkers and clinical diagnostic tests.

Yuling Luo, PhD, president and CEO of ACD, said, "This advanced image analysis solution will bring objective and accurate quantification to RNAscope and enable a new generation of diagnostic applications such as circulating tumor cell detection and molecular analysis. For the first time, gene expression can be measured quantitatively at single cell resolution and interpreted by pathologists within histopathological context."

Related Links:

Advanced Cell Diagnostics
Definiens



Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Automatic Biochemistry Analyzer
Audmax 180 Evolution
New
Histamine ELISA
Histamine ELISA

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests